A.R.T. Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
BG
TS
SCM
A.R.T. Advisors's HALO Position: Q1 2020 in Review
A.R.T. Advisors sold out of Halozyme (HALO) in Q1 2020, closing a stake of 39,141 shares — an estimated $694K sold.
A.R.T. Advisors first reported a position in HALO in Q2 2013 and held it in 15 quarters. The position peaked at $4.03M in Q4 2017. 209 funds tracked by Wall St. Rank hold HALO as of Q1 2020.
- A.R.T. Advisors reported no remaining Halozyme position as of Q1 2020 after selling out during the quarter.
- A.R.T. Advisors sold 39,141 Halozyme shares in Q1 2020, an estimated $694K.
- A.R.T. Advisors first reported a position in Halozyme in Q2 2013 and held it in 15 quarters.
- A.R.T. Advisors's Halozyme position peaked at $4.03M in Q4 2017.
- 209 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.
Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.